Qualis Innovations, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLIS research report →
Price Chart
About the company
Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and distribution of solutions primarily targeting pain management and other disorders affecting the central nervous system (CNS). The company's flagship product is SOLACE, an advanced, non-invasive medical device.
- CEO
- Patrick S. Adams CFA
- IPO
- 2007
- HQ
- Chadds Ford, PA, US
Get TickerSpark's AI analysis on QLIS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.45M
- P/E
- -142.19
- PEG
- 2.93
- P/S
- 17.96
- P/B
- 27.82
- EV/EBITDA
- -422.54
- Div Yield
- 0.00%
- Gross Margin
- 92.99%
- Op Margin
- -8.41%
- Net Margin
- -10.12%
- ROE
- -18.13%
- ROIC
- -8.52%
Latest fiscal year · YoY change
- Revenue
- $221.76K+0.0%
- Gross Profit
- $221.76K+0.0%
- Op Income
- $-501,079
- Net Income
- $-492,748-390.4%
- EPS
- $-0.02-300.0%
- OCF Growth
- -193.4%
- FCF Growth
- -193.4%
- 52W High
- $0.94
- 52W Low
- $0.26
- 50D MA
- $0.27
- 200D MA
- $0.28
- Beta
- -2.76
- RSI (14)
- 44
- Avg Volume
- 33
No earnings-call transcripts are available for QLIS yet.
- Free Float
- 43.5%
- Shares Outstanding
- 20.44M
- Float Shares
- 8.90M
of shares held by institutions
1 13F filers
Our QLIS coverage
Recent articles, reports, and earnings notes.
No research on QLIS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QLIS report →